These outcomes, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assistance the idea of focusing on ACKR3 as a singular strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders.The site is protected. The https:/